Specialty Pharmacy

Top news of the day from across the health care landscape.

Highly active antiretroviral therapy (HAART) prolongs survival for patients with HIV, but increases the risk for other chronic diseases.

The FDA has announced a new research model that may expedite research and development for a Zika virus vaccine.

Clinical outcomes have different meanings among specialty pharmacy stakeholders.

Researchers able to predict treatment response to TNFI drugs and rituximab in RA patients.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how specialty stakeholders can accurately encapsulate the high volume of data they produce to improve operations.

Top news of the day from across the health care landscape.

Two existing drugs, Gemcitabine and DON, target the degradation of nucleotides in the liver.

Growing evidence points to the relationship between rheumatoid arthritis and heart problems.

African Americans have the most severe burden of HIV in the United States.

Top news of the week in oncology and cancer drug development.

Promising data on pediatric relapsed/refractory acute lymphoblastic leukemia to be presented.

Researchers have identified an antibody that can neutralize 98% of HIV strains, and may serve as a potential candidate for future HIV treatment and prevention.

Cognitive and physical fitness may play a role in the development of ALS.

Top news of the week on Specialty Pharmacy Times.

Targeting TAZ can essentially stop fibrosis and may provide future treatment options for patients with nonalcoholic steatohepatitis.

Top news of the day from across the health care landscape.

Patients with rheumatoid arthritis want a fast-acting, orally administered treatment for their symptoms.

A better understanding of the mechanisms of arthritis is needed to develop superior treatments.

Viral loads were reduced in SIV-infected rhesus monkeys given an experimental vaccine in combination with an immune stimulant.

A simple questionnaire and testing can help identify more patients with chronic obstructive pulmonary disease.

Top news of the day from across the health care landscape.

Baricitinib significantly improved patient-reported outcomes in individuals with RA.

New drugs for psoriatic arthritis discussed during a session at the ACR/ARHP conference.

At the Annual Meeting of the American College of Rheumatology in Washington, DC, several experts presented their progress in harnessing technology to help teenagers and young adults manage their juvenile arthritis.

Study compares the safety and efficacy of sarilumab with adalimumab in patients who cannot tolerate methotrexate.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Combination immunotherapy more successful in treating advanced skin cancer.

An ACR session focused on the Sunshine Act and health care transparency.